Zimmer Biomet Holdings Inc (N:ZBH)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 345 E Main St
WARSAW IN 46580-2746
Tel: N/A
Website: www.zimmerbiomet.com
IR: See website
Key People
Bryan C. Hanson
President, Chief Executive Officer, Director
Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President
Aure Bruneau
Group President, Spine, CMF, Thoracic and Surgery Assisting Technology
Ivan Tornos
Group President, Orthopedics
Sang Yi
President, Asia Pacific
Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Keri P. Mattox
Senior Vice President - Investor Relations, Chief Communications Officer
Carrie Ann Nichol
Chief Accounting Officer, Vice President, Controller
Business Overview
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
Financial Overview
For the fiscal year ended 31 December 2019, Zimmer Biomet Holdings Inc revenues increased 1% to $7.98B. Net income before extraordinary items totaled $1.13B vs. loss of $370.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Acquisition, integration and related decrease of 91% to $12.2M (expense), Quality remediation decrease of 44% to $82.4M (expense), Selling.
Employees: 19,000 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $40,517M as of Dec 31, 2019
Annual revenue (TTM): $7,982M as of Dec 31, 2019
EBITDA (TTM): $2,441M as of Dec 31, 2019
Net annual income (TTM): $1,132M as of Dec 31, 2019
Free cash flow (TTM): $668.50M as of Dec 31, 2019
Net Debt Last Fiscal Year: $7,604M as of Dec 31, 2019
Shares outstanding: 205,684,362 as of Dec 31, 2019
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization